Revenue (Tables)

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Summary of disaggregation of revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Three Months Ended March 31,
	2022		2021
Patient services
Capitated revenue	$	14,516	$	12,330
FFS revenue	20,541		17,292
Subtotal	35,057		29,622
Dispensary revenue	18,679		17,618
Clinical research trials and other revenue	1,425		1,340
Total	$	55,161	$	48,580